Biotechnology Startups That Raised Funding in Ireland

Prothena

Location: Dublin, Ireland

Website: prothena.com

Funding: Raised to $12.00

Date: 125 days ago

Prothena is a clinical-stage biotechnology company that discovers and develops protein-targeted therapeutics for immunology and neuroscience disorders.

Aerska

Location: Dublin, Ireland

Website: aerska.com

Funding: raises $39M

Date: 135 days ago

Aerska is a Dublin-based biotech company developing proprietary delivery platforms to transport RNA-based therapeutics across the blood-brain barrier, enabling the development of treatments for neurodegenerative diseases.

Aerska

Location: Dublin, Ireland

Funding: raises $39m

Date: 136 days ago

Aerska is a Dublin-based biotech firm developing RNA interference (RNAi) therapeutics designed to reach the brain and switch off harmful genes linked to neurological diseases such as Alzheimer’s.

Aerska

Location: Ireland

Funding: raises $39M

Date: 136 days ago

Aerska develops brain shuttle technology to deliver RNAi therapeutics across the blood-brain barrier, enabling targeted treatment of neurological disorders.

Prothena

Location: -

Funding: Raised to $30.00

Date: 228 days ago

Prothena is a clinical-stage biotechnology company focused on discovering and developing novel therapies for neurodegenerative and systemic amyloid diseases.

Prothena

Location: -

Funding: Raised to $11.00

Date: 230 days ago

Prothena is a clinical-stage biotechnology company developing antibody-based therapies targeting protein dysregulation in neuroscience, immunology and oncology, with a focus on amyloidosis and related neurodegenerative disorders.

Amply Discovery

Location: Belfast, Northern Ireland

Funding: raises $1.75m

Date: 421 days ago

Amply Discovery is a biotech firm leveraging a proprietary AI-driven platform to accelerate the discovery of innovative medicines, particularly targeting cancer therapies.

Amply

Location: Belfast, Northern Ireland

Website: amply.bio

Funding: raises $1.75m

Date: 421 days ago

Amply is a biotech firm leveraging its AI-driven drug discovery platform to develop innovative medicines targeting aggressive cancers and drug-resistant pathogens.